Af­ter safe­ty re­view, EMA mir­rors FDA with up­dat­ed rec­om­men­da­tions for JAK in­hibitors

The EMA re­leased up­dat­ed rec­om­men­da­tions to­day for the use of JAK in­hibitors (JA­Ki) af­ter re­view­ing da­ta from sev­er­al clin­i­cal tri­als that showed in­creased in­ci­dents of …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER